Clinical Trials Browser

Phase 2 × Has results × Estradiol × Clear all

NCT03941730 2026-05-12

Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer

Phase 2 Active not recruiting

8 enrolled 9 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01923298 2022-02-10

Estradiol Levels in Patients Treated With Estring

Phase 2 Completed

14 enrolled 4 charts

Estrogen Levels Among Breast Cancer Patients

NCT01441635 2021-07-13

Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids

Phase 2 Completed

271 enrolled 38 charts

Leiomyoma, Menorrhagia

NCT01817530 2020-07-21

Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)

Phase 2 Completed

571 enrolled 32 charts

Leiomyoma, Menorrhagia

NCT02455453 2020-01-14

Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography

Phase 2 Completed

47 enrolled 8 charts

Breast Neoplasms

NCT01083641 2019-12-09

Estrogen for Triple Negative Breast Cancer

Phase 2 Terminated

17 enrolled 10 charts

Breast Neoplasms

NCT00661531 2017-04-12

Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy

Phase 2 Terminated

11 enrolled 8 charts

Breast Neoplasms

NCT00586898 2016-03-25

Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle

Phase 2 Completed

36 enrolled 6 charts

Neoplasms

NCT00324259 2015-02-16

Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer

Phase 2 Completed

66 enrolled 13 charts

Breast Neoplasms

NCT00698035 2014-06-02

E-String

Phase 2 Completed

76 enrolled 11 charts

Sexual Dysfunction, Physiological